Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
7.48
-0.29 (-3.73%)
At close: Sep 12, 2025, 4:00 PM EDT
7.52
+0.04 (0.53%)
After-hours: Sep 12, 2025, 4:57 PM EDT
Lifecore Biomedical Stock Forecast
Stock Price Forecast
The 2 analysts that cover Lifecore Biomedical stock have a consensus rating of "Buy" and an average price target of $8.00, which forecasts a 6.95% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $10.
Price Target: $8.00 (+6.95%)
Analyst Consensus: Buy
* Price targets were last updated on Jan 3, 2025.
Analyst Ratings
The average analyst rating for Lifecore Biomedical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 1 | 1 | 1 | 1 | 1 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Keybanc | Keybanc | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 4, 2025 |
William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | May 21, 2025 |
Stephens & Co. | Stephens & Co. | Hold Reiterates $6 | Hold | Reiterates | $6 | -19.79% | Jan 3, 2025 |
Craig-Hallum | Craig-Hallum | Strong Buy Maintains $8 → $10 | Strong Buy | Maintains | $8 → $10 | +33.69% | Nov 22, 2024 |
Craig-Hallum | Craig-Hallum | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +6.95% | Sep 5, 2024 |
Financial Forecast
Revenue This Year
134.94M
from 128.87M
Increased by 4.71%
Revenue Next Year
149.75M
from 134.94M
Increased by 10.98%
EPS This Year
-0.74
from -1.27
EPS Next Year
-0.44
from -0.74
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|
High | 144.1M | 157.8M | |||
Avg | 134.9M | 149.8M | |||
Low | 126.6M | 139.6M |
Revenue Growth
Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|
High | 11.8% | 17.0% | |||
Avg | 4.7% | 11.0% | |||
Low | -1.7% | 3.4% |
EPS Forecast
EPS | 2026 | 2027 | 2028 |
---|---|---|---|
High | -0.64 | -0.45 | |
Avg | -0.74 | -0.44 | |
Low | -0.82 | -0.42 |
EPS Growth
EPS Growth | 2026 | 2027 | 2028 |
---|---|---|---|
High | - | - | |
Avg | - | - | |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.